Pulmonary surfactant inhibition of nanoparticle uptake by alveolar epithelial cells
M. Radiom, M. Sarkis, O. Brookes, E.K. Oikonomou, A. Baeza-Squiban and, J.-F. Berret

TL;DR
This study demonstrates that pulmonary surfactant significantly reduces nanoparticle uptake by alveolar epithelial cells, highlighting its protective role and implications for nanoparticle toxicity assessment and drug delivery.
Contribution
The paper introduces an in vitro model showing how pulmonary surfactant inhibits nanoparticle uptake, providing insights into its protective mechanism in the lungs.
Findings
Surfactant decreases nanoparticle uptake by up to two orders of magnitude.
Nanoparticles form mixed aggregates with surfactant lipids.
Surfactant's protective effect is consistent across different cell models.
Abstract
Pulmonary surfactant forms a sub-micrometer thick fluid layer that covers the surface of alveolar lumen and inhaled nanoparticles therefore come in to contact with surfactant prior to any interaction with epithelial cells. We investigate the role of the surfactant as a protective physical barrier by modeling the interactions using silica-Curosurf-alveolar epithelial cell system in vitro. Electron microscopy displays that the vesicles are preserved in the presence of nanoparticles while nanoparticle-lipid interaction leads to the formation of mixed aggregates. Fluorescence microscopy reveals that the surfactant decreases the uptake of nanoparticles by up to two orders of magnitude in two models of alveolar epithelial cells, A549 and NCI-H441, irrespective of immersed culture on glass or air-liquid interface culture on transwell. Confocal microscopy corroborates the results by showing…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
